Devices › Device types
FDA product code OCY · class 2 · Gastroenterology, Urology
Endoscopic guidewire, gastroenterology-urology: medical device reports filed with FDA
1,645 reports carry this product code, 2007–2026; 7 brands with a page.
- 1,645
- reports with this product code
- 0% of all MAUDE reports
- 111
- reports, 12 months to August 2026
- 137 in the 12 months before
- 81.5%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code OCY is FDA's classification for "Endoscopic guidewire, gastroenterology-urology" (gastroenterology, Urology panel), a class 2 device. 1,645 medical device reports carry this product code, 0% of the MAUDE database, from November 2007 to August 2026.
111 reports arrived in the 12 months to August 2026, down 19% from 137 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (81.5%), injury (18%) and death (0.2%). 7 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Jagwire | 484 | 22 | 0.7% | 82.3% |
| Acrobat Calibrated Tip Wire Guide | 222 | 0 | 0% | 97.3% |
| Hiwire Nitinol Hydrophilic Wire Guide | 146 | 9 | 0% | 78% |
| Amplatz Super Stiff | 4 | 50 | 4.7% | 77.1% |
| Cook Bakri Postpartum Balloon with Rapid Instillation Components | 2 | 52 | 0.3% | 74.2% |
| Guidewire | 2 | 15 | 0.6% | 77.3% |
| Amplatz Super Stiff Guidewire | 1 | 0 | 3% | 80.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific - Costa Rica Coyol | 374 | 22.7% |
| Cook Endoscopy | 252 | 15.3% |
| Wilson-Cook Medical | 169 | 10.3% |
| Terumo Ashitaka | 127 | 7.7% |
| Cook | 97 | 5.9% |
| Consolidated Medical Equipment | 45 | 2.7% |
| Terumo Medical | 38 | 2.3% |
| Asahi Intecc | 21 | 1.3% |
| Lake Region Medical | 13 | 0.8% |
| Terumo | 12 | 0.7% |
| Conmed | 6 | 0.4% |
| Animas | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Peeled/delaminated | 564 | 34.3% |
| Detachment of device component | 387 | 23.5% |
| Material separation | 167 | 10.2% |
| Breakthe device broke | 144 | 8.8% |
| Detachment of device or device componentpart of the device came off | 41 | 2.5% |
| Fracturea broken bone | 35 | 2.1% |
| Material fragmentation | 28 | 1.7% |
| Positioning problem | 23 | 1.4% |
| Material twisted/bent | 21 | 1.3% |
| Migration or expulsion of device | 21 | 1.3% |
| Unraveled material | 21 | 1.3% |
| Material deformation | 19 | 1.2% |
| Difficult to advance | 17 | 1% |
| Insufficient device problem information | 15 | 0.9% |
| Entrapment of device | 12 | 0.7% |
| Deformation due to compressive stress | 10 | 0.6% |
| Device damaged by another device | 10 | 0.6% |
| Device contaminated during manufacture or shipping | 9 | 0.5% |
| Flaked | 9 | 0.5% |
| Device damaged prior to usethe device was damaged before use | 8 | 0.5% |
Questions about endoscopic guidewire, gastroenterology-urology reports
What is product code OCY?
FDA's classification code for "Endoscopic guidewire, gastroenterology-urology", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,645 reports through August 2026, 111 of them in the latest 12 months.
Which brands appear most often?
Jagwire (484), Acrobat Calibrated Tip Wire Guide (222), Hiwire Nitinol Hydrophilic Wire Guide (146), Amplatz Super Stiff (4) and Cook Bakri Postpartum Balloon with Rapid Instillation Components (2). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.